会員登録
ログイン
【3386】コスモ・バイオ
研究用試薬などの商社。
業績予想修正履歴
| 決算期 | 日付 | 予・実 | 売上高 (百万円) |
対前回 | 修正率 | 修正率 | 営業利益 (百万円) |
対前回 | 修正率 | 修正率 | 経常利益 (百万円) |
対前回 | 修正率 | 修正率 | 当期利益 (百万円) |
対前回 | 修正率 | 修正率 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024.12 | 2024/02/14 | 当初予 | 9,800 | - | - | - | 390 | - | - | - | 450 | - | - | - | 310 | - | - | - |
| 2023.12 | 2024/02/14 | 実 | 9,340 | ↓ | -4.7% | -4.7% | 519 | ↓ | -13.5% | -13.5% | 653 | ↓ | -1.1% | -1.1% | 442 | ↓ | -1.8% | -1.8% |
| 2023.12 | 2023/11/07 | Q3予 | 9,800 | → | 0.0% | 0.0% | 600 | → | 0.0% | 0.0% | 660 | → | 0.0% | 0.0% | 450 | → | 0.0% | 0.0% |
| 2023.12 | 2023/08/04 | Q2予 | 9,800 | → | 0.0% | 0.0% | 600 | → | 0.0% | 0.0% | 660 | → | 0.0% | 0.0% | 450 | → | 0.0% | 0.0% |
| 2023.12 | 2023/05/10 | Q1予 | 9,800 | → | 0.0% | 0.0% | 600 | → | 0.0% | 0.0% | 660 | → | 0.0% | 0.0% | 450 | → | 0.0% | 0.0% |
| 2023.12 | 2023/02/14 | 当初予 | 9,800 | - | - | - | 600 | - | - | - | 660 | - | - | - | 450 | - | - | - |
| 2022.12 | 2023/02/14 | 実 | 9,553 | ↓ | -0.5% | +1.6% | 816 | ↑ | +16.6% | -1.7% | 790 | ↑ | +11.3% | -9.2% | 517 | ↑ | +10.0% | -10.9% |
| 2022.12 | 2022/11/07 | Q3予 | 9,600 | → | 0.0% | +2.1% | 700 | → | 0.0% | -15.7% | 710 | → | 0.0% | -18.4% | 470 | → | 0.0% | -19.0% |
| 2022.12 | 2022/08/04 | Q2予 | 9,600 | → | 0.0% | +2.1% | 700 | → | 0.0% | -15.7% | 710 | → | 0.0% | -18.4% | 470 | → | 0.0% | -19.0% |
| 2022.12 | 2022/07/25 | 修正予 | 9,600 | ↑ | +2.1% | +2.1% | 700 | ↓ | -15.7% | -15.7% | 710 | ↓ | -18.4% | -18.4% | 470 | ↓ | -19.0% | -19.0% |
| 2022.12 | 2022/05/10 | Q1予 | 9,400 | → | 0.0% | 0.0% | 830 | → | 0.0% | 0.0% | 870 | → | 0.0% | 0.0% | 580 | → | 0.0% | 0.0% |
| 2022.12 | 2022/02/14 | 当初予 | 9,400 | - | - | - | 830 | - | - | - | 870 | - | - | - | 580 | - | - | - |
| 2021.12 | 2022/02/14 | 実 | 9,231 | ↑ | +2.6% | +12.6% | 1,048 | ↑ | +16.4% | +49.7% | 1,099 | ↑ | +15.7% | +46.5% | 737 | ↑ | +17.0% | +53.5% |
| 2021.12 | 2021/11/05 | Q3予 | 9,000 | → | 0.0% | +9.8% | 900 | → | 0.0% | +28.6% | 950 | → | 0.0% | +26.7% | 630 | → | 0.0% | +31.3% |
| 2021.12 | 2021/08/05 | Q2予 | 9,000 | → | 0.0% | +9.8% | 900 | → | 0.0% | +28.6% | 950 | → | 0.0% | +26.7% | 630 | → | 0.0% | +31.3% |
| 2021.12 | 2021/07/27 | 修正予 | 9,000 | ↑ | +9.8% | +9.8% | 900 | ↑ | +28.6% | +28.6% | 950 | ↑ | +26.7% | +26.7% | 630 | ↑ | +31.3% | +31.3% |
| 2021.12 | 2021/05/10 | Q1予 | 8,200 | → | 0.0% | 0.0% | 700 | → | 0.0% | 0.0% | 750 | → | 0.0% | 0.0% | 480 | → | 0.0% | 0.0% |
| 2021.12 | 2021/02/12 | 当初予 | 8,200 | - | - | - | 700 | - | - | - | 750 | - | - | - | 480 | - | - | - |
| 2020.12 | 2021/02/12 | 実 | 8,092 | ↑ | +3.7% | +4.4% | 752 | ↑ | +27.5% | +74.9% | 817 | ↑ | +23.8% | +66.7% | 674 | ↑ | +24.8% | +117.4% |
| 2020.12 | 2020/11/06 | Q3予 | 7,800 | → | 0.0% | +0.6% | 590 | → | 0.0% | +37.2% | 660 | → | 0.0% | +34.7% | 540 | → | 0.0% | +74.2% |
| 2020.12 | 2020/08/05 | Q2予 | 7,800 | → | 0.0% | +0.6% | 590 | → | 0.0% | +37.2% | 660 | → | 0.0% | +34.7% | 540 | → | 0.0% | +74.2% |
| 2020.12 | 2020/07/21 | 修正予 | 7,800 | ↑ | +0.6% | +0.6% | 590 | ↑ | +37.2% | +37.2% | 660 | ↑ | +34.7% | +34.7% | 540 | ↑ | +74.2% | +74.2% |
| 2020.12 | 2020/05/11 | Q1予 | 7,750 | → | 0.0% | 0.0% | 430 | → | 0.0% | 0.0% | 490 | → | 0.0% | 0.0% | 310 | → | 0.0% | 0.0% |
| 2020.12 | 2020/02/14 | 当初予 | 7,750 | - | - | - | 430 | - | - | - | 490 | - | - | - | 310 | - | - | - |
| 2019.12 | 2020/02/14 | 実 | 7,590 | ↑ | +2.6% | +2.6% | 405 | ↑ | +15.7% | +102.5% | 470 | ↑ | +22.1% | +88.0% | 237 | ↓ | -5.2% | +69.3% |
| 2019.12 | 2019/11/06 | Q3予 | 7,400 | → | 0.0% | 0.0% | 350 | → | 0.0% | +75.0% | 385 | → | 0.0% | +54.0% | 250 | → | 0.0% | +78.6% |
| 2019.12 | 2019/08/05 | Q2予 | 7,400 | → | 0.0% | 0.0% | 350 | → | 0.0% | +75.0% | 385 | → | 0.0% | +54.0% | 250 | → | 0.0% | +78.6% |
| 2019.12 | 2019/07/23 | 修正予 | 7,400 | → | 0.0% | 0.0% | 350 | ↑ | +75.0% | +75.0% | 385 | ↑ | +54.0% | +54.0% | 250 | ↑ | +78.6% | +78.6% |
| 2019.12 | 2019/05/10 | Q1予 | 7,400 | → | 0.0% | 0.0% | 200 | → | 0.0% | 0.0% | 250 | → | 0.0% | 0.0% | 140 | → | 0.0% | 0.0% |
| 2019.12 | 2019/02/14 | 当初予 | 7,400 | - | - | - | 200 | - | - | - | 250 | - | - | - | 140 | - | - | - |
| 2018.12 | 2019/02/14 | 実 | 7,261 | → | 0.0% | -3.2% | 328 | ↑ | +0.6% | +68.2% | 403 | ↑ | +0.2% | +64.5% | 260 | ↑ | +0.4% | +73.3% |
| 2018.12 | 2019/01/31 | 修正予 | 7,261 | ↓ | -3.2% | -3.2% | 326 | ↑ | +67.2% | +67.2% | 402 | ↑ | +64.1% | +64.1% | 259 | ↑ | +72.7% | +72.7% |
| 2018.12 | 2018/11/05 | Q3予 | 7,500 | → | 0.0% | 0.0% | 195 | - | - | - | 245 | → | 0.0% | 0.0% | 150 | → | 0.0% | 0.0% |
| 2018.12 | 2018/05/08 | 当初予 | 7,500 | - | - | - | - | - | - | - | 245 | - | - | - | 150 | - | - | - |
| 2017.12 | 2018/02/14 | 実 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| 2017.12 | 2018/02/14 | FY予 | 7,068 | ↓ | -1.8% | -5.8% | 193 | ↑ | +37.9% | +67.8% | 397 | ↑ | +10.3% | +120.6% | 237 | ↑ | +3.0% | +125.7% |
| 2017.12 | 2017/11/06 | Q3予 | 7,200 | → | 0.0% | -4.0% | 140 | → | 0.0% | +21.7% | 360 | → | 0.0% | +100.0% | 230 | → | 0.0% | +119.0% |
| 2017.12 | 2017/08/04 | 修正予 | 7,200 | ↓ | -4.0% | -4.0% | 140 | ↑ | +21.7% | +21.7% | 360 | ↑ | +100.0% | +100.0% | 230 | ↑ | +119.0% | +119.0% |
| 2017.12 | 2017/05/09 | Q1予 | 7,500 | → | 0.0% | 0.0% | 115 | → | 0.0% | 0.0% | 180 | → | 0.0% | 0.0% | 105 | → | 0.0% | 0.0% |
| 2017.12 | 2017/02/14 | 当初予 | 7,500 | - | - | - | 115 | - | - | - | 180 | - | - | - | 105 | - | - | - |
| 2016.12 | 2017/02/14 | 実 | 7,427 | ↓ | -2.3% | -4.2% | 514 | ↑ | +28.5% | +328.3% | 483 | ↑ | +27.1% | +119.5% | 254 | ↑ | +5.8% | +111.7% |
| 2016.12 | 2016/11/07 | Q3予 | 7,600 | → | 0.0% | -1.9% | 400 | → | 0.0% | +233.3% | 380 | → | 0.0% | +72.7% | 240 | → | 0.0% | +100.0% |
| 2016.12 | 2016/08/05 | 修正予 | 7,600 | ↓ | -1.9% | -1.9% | 400 | ↑ | +233.3% | +233.3% | 380 | ↑ | +72.7% | +72.7% | 240 | ↑ | +100.0% | +100.0% |
| 2016.12 | 2016/02/12 | 当初予 | 7,750 | - | - | - | 120 | - | - | - | 220 | - | - | - | 120 | - | - | - |
| 2015.12 | 2016/02/12 | 実 | 7,357 | → | 0.0% | -5.2% | 200 | → | 0.0% | +185.7% | 373 | → | 0.0% | +86.5% | 230 | ↓ | -0.4% | +91.7% |
| 2015.12 | 2016/01/27 | 修正予 | 7,357 | ↓ | -5.2% | -5.2% | 200 | ↑ | +122.2% | +185.7% | 373 | ↑ | +38.1% | +86.5% | 231 | ↑ | +44.4% | +92.5% |
| 2015.12 | 2015/11/09 | Q3予 | 7,760 | → | 0.0% | 0.0% | 90 | → | 0.0% | +28.6% | 270 | → | 0.0% | +35.0% | 160 | → | 0.0% | +33.3% |
| 2015.12 | 2015/08/10 | 修正予 | 7,760 | → | 0.0% | 0.0% | 90 | ↑ | +28.6% | +28.6% | 270 | ↑ | +35.0% | +35.0% | 160 | ↑ | +33.3% | +33.3% |
| 2015.12 | 2015/05/08 | Q1予 | 7,760 | → | 0.0% | 0.0% | 70 | - | - | - | 200 | → | 0.0% | 0.0% | 120 | → | 0.0% | 0.0% |
| 2015.12 | 2015/02/13 | 当初予 | 7,760 | - | - | - | - | - | - | - | 200 | - | - | - | 120 | - | - | - |
| 2014.12 | 2015/02/13 | 実 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| 2014.12 | 2015/01/26 | 修正予 | 7,235 | ↓ | -0.9% | -0.9% | - | - | - | - | 285 | ↓ | -30.5% | -27.7% | 201 | ↓ | -24.2% | -13.7% |
| 2014.12 | 2014/11/06 | Q3予 | 7,300 | → | 0.0% | 0.0% | 260 | → | 0.0% | +0.8% | 410 | → | 0.0% | +4.1% | 265 | → | 0.0% | +13.7% |
| 2014.12 | 2014/08/07 | 修正予 | 7,300 | → | 0.0% | 0.0% | 260 | ↑ | +0.8% | +0.8% | 410 | ↑ | +4.1% | +4.1% | 265 | ↑ | +13.7% | +13.7% |
| 2014.12 | 2014/05/08 | Q1予 | 7,300 | → | 0.0% | 0.0% | 258 | → | 0.0% | 0.0% | 394 | → | 0.0% | 0.0% | 233 | → | 0.0% | 0.0% |
| 2014.12 | 2014/02/14 | 当初予 | 7,300 | - | - | - | 258 | - | - | - | 394 | - | - | - | 233 | - | - | - |
| 2013.12 | 2014/02/14 | 実 | 7,050 | - | - | - | 271 | - | - | - | 444 | - | - | - | 313 | - | - | - |
